Cost Recovery Implementation Statement (CRIS) – Administration of the Prescribed List of Medical Devices and Human Tissue Products 2026-2027

The CRIS draft for consultation provides information on how we implement cost recovery charging for applications for medical devices seeking to be listed on the Prescribed List of Medical Devices and Human Tissue Products.